Long-term anifrolumab safe in SLE. | Nat Rev Rheumatol;19(2): 64, 2023 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Long-term anifrolumab safe in SLE.

McHugh, Jessica.

McHugh J; Nature Reviews Rheumatology, . nrrheum@nature.com.

Nat Rev Rheumatol ; 19(2): 64, 2023 02.

Article in English | MEDLINE | ID: covidwho-2299848

Subject(s)

Antibodies, Monoclonal, Humanized; Lupus Erythematosus, Systemic; Humans; Antibodies, Monoclonal, Humanized/adverse effects; Antibodies, Monoclonal/adverse effects; Lupus Erythematosus, Systemic/drug therapy

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Lupus Erythematosus, Systemic Limits: Humans Language: English Journal: Nat Rev Rheumatol Journal subject: Rheumatology Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Lupus Erythematosus, Systemic Limits: Humans Language: English Journal: Nat Rev Rheumatol Journal subject: Rheumatology Year: 2023 Document Type: Article